Related references
Note: Only part of the references are listed.Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability
Hong-Xin Cui et al.
MOLECULES (2019)
Multi-Target Drugs Against Metabolic Disorders
Luciana Scotti et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2019)
Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice
Minglin Pan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
Nishanth E. Sunny et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
Li Zhao et al.
BMC ENDOCRINE DISORDERS (2017)
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome
Rachel J. Perry et al.
NATURE (2016)
Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
Honglin Sun et al.
OBESITY FACTS (2016)
Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
Ting Guo et al.
SCIENTIFIC REPORTS (2016)
Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies
Prasenjit Manna et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2015)
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
Hong-Mei Yan et al.
PLOS ONE (2015)
Transforming berberine into its intestine-absorbable form by the gut microbiota
Ru Feng et al.
SCIENTIFIC REPORTS (2015)
Effects of Berberine on Amelioration of Hyperglycemia and Oxidative Stress in High Glucose and High Fat Diet-Induced Diabetic Hamsters In Vivo
Cong Liu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models
Deepak K. Rajpal et al.
PLOS ONE (2015)
Learning from berberine: Treating chronic diseases through multiple targets
Yao Jing et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Intestinal absorption of berberine and 8-hydroxy dihydroberberine and their effects on sugar absorption in rat small intestine
Shi-chao Wei et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2014)
Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption
Yanwen Wang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
Yueshan Hu et al.
PLOS ONE (2014)
Berberine activates thermogenesis in white and brown adipose tissue
Zhiguo Zhang et al.
NATURE COMMUNICATIONS (2014)
The GLP-1 Analogue Exenatide Improves Hepatic and Muscle Insulin Sensitivity in Diabetic Rats: Tracer Studies in the Basal State and during Hyperinsulinemic-Euglycemic Clamp
Hui Wu et al.
JOURNAL OF DIABETES RESEARCH (2014)
Genetic Control of Obesity and Gut Microbiota Composition in Response to High-Fat, High-Sucrose Diet in Mice
Brian W. Parks et al.
CELL METABOLISM (2013)
Effects of berberine on lipid profile in subjects with low cardiovascular risk
Giuseppe Derosa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
The effect of gut microbiota on drug metabolism
Mi Jeong Kang et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans
Fei Cheng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State
Isabella Savini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
Karina G. Perez-Rubio et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2013)
Berberine Ameliorates Chronic Kidney Injury Caused by Atherosclerotic Renovascular Disease through the Suppression of NFκB Signaling Pathway in Rats
Xin Wan et al.
PLOS ONE (2013)
Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
Shu Meng et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
Hui Dong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials (Publication with Expression of Concern. See vol. 13, pg. 177, 2018)
Giuseppe Derosa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations
Chenhong Zhang et al.
ISME JOURNAL (2012)
The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
Xin-xia Chang et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Functional interactions between the gut microbiota and host metabolism
Valentina Tremaroli et al.
NATURE (2012)
Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats
Xu Zhang et al.
PLOS ONE (2012)
Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats
Wei Chen et al.
AAPS PHARMSCITECH (2011)
Berberine-Improved Visceral White Adipose Tissue Insulin Resistance Associated with Altered Sterol Regulatory Element-Binding Proteins, Liver X Receptors, and Peroxisome Proliferator-Activated Receptors Transcriptional Programs in Diabetic Hamsters
Guo-Sheng Li et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver
Lian-Jun Xing et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
Qian Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Mitochondrial energy metabolism and redox responses to hypertriglyceridemia
Luciane C. Alberici et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2011)
Gut microbiome, obesity, and metabolic dysfunction
Herbert Tilg et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Activation of AMP-Activated Protein Kinase Is Required for Berberine-Induced Reduction of Atherosclerosis in Mice: The Role of Uncoupling Protein 2
Qilong Wang et al.
PLOS ONE (2011)
Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice
Weidong Xie et al.
PLOS ONE (2011)
Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery
Sunil Kumar Battu et al.
AAPS PHARMSCITECH (2010)
Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages
Lindsei K. Sarna et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
Yi-Tong Liu et al.
DRUG METABOLISM AND DISPOSITION (2010)
Berberine inhibits adipogenesis in high-fat diet-induced obesity mice
Yueshan Hu et al.
FITOTERAPIA (2010)
Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics
Nathalie M. Delzenne et al.
INTERNATIONAL DAIRY JOURNAL (2010)
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
Chenhong Zhang et al.
ISME JOURNAL (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity
Woo Sik Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Berberine suppresses proinflammatory responses through AMPK activation in macrophages
Hyun Woo Jeong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives
Arrigo Francesco Giuseppe Cicero et al.
BLOOD PRESSURE (2009)
Tissue Inhibitor of Metalloproteinase 3 Deficiency Causes Hepatic Steatosis and Adipose Tissue Inflammation in Mice
Rossella Menghini et al.
GASTROENTEROLOGY (2009)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
All-trans-Retinoic Acid Represses Obesity and Insulin Resistance by Activating both Peroxisome Proliferation-Activated Receptor β/δ and Retinoic Acid Receptor
Daniel C. Berry et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis
Wei Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2
Ricardo Rodriguez-Calvo et al.
DIABETES (2008)
The gastrointestinal microbiota as a site for the biotransformation of drugs
Tiago Sousa et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Are biologists in 'future shock'? Symbiosis integrates biology across domains
Margaret McFall-Ngai
NATURE REVIEWS MICROBIOLOGY (2008)
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells
Yih-Shou Hsieh et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine
Jean-Marie Brusq et al.
JOURNAL OF LIPID RESEARCH (2006)
Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity
S Franckhauser et al.
DIABETES (2006)
AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle
AC Smith et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
AMP kinase and malonyl-CoA: Targets for therapy of the metabolic syndrome
N Ruderman et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Glyceroneogenesis revisited
RW Hanson et al.
BIOCHIMIE (2003)
Cardiovascular disease
EG Nabel
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Minireview: Malonyl CoA, AMP-activated protein kinase, and adiposity
NB Ruderman et al.
ENDOCRINOLOGY (2003)
Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?
JL Evans et al.
DIABETES (2003)
The involvement of P-glycoprotein in berberine absorption
GY Pan et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression
H Kaneto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells
V Scivittaro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2000)
Share Paper
